TARGETED LIPOSOMES IN CANCER THERAPY
The invention provides pharmaceutical compositions containing a vehicle for the targeted delivery of therapeutic and diagnostic agents for the treatment of hyperproliferative diseases. The targeting component of the vehicle is a cystine molecule that is coupled to the cargo component, which can be e...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides pharmaceutical compositions containing a vehicle for the targeted delivery of therapeutic and diagnostic agents for the treatment of hyperproliferative diseases. The targeting component of the vehicle is a cystine molecule that is coupled to the cargo component, which can be either a therapeutic or diagnostic agent or to a nanoparticle composition that contains the therapeutic agent or diagnostic. The invention also provides methods of treating hyperproliferative disorders by targeting hyperproliferative disease cells for the targeted delivery of a therapeutic or diagnostic agent. |
---|---|
Bibliography: | Application Number: EP20120830510 |